Ran Geng

Principal @ OrbiMed

About

GengR@OrbiMed.com I invest in biotech companies with a clear path to disrupt treatment paradigm of diseases. Also invest in technologies that address the inequality of healthcare resources or inefficiency of healthcare delivery. Help companies reduce development costs.

Country

United States

City

San Francisco Bay Area

Industry

Venture Capital & Private Equity

Skill

Life Sciences, Biopharmaceuticals, Entrepreneurship, Healthcare, Data Analysis, Statistics, R&D, Drug Development, Marketing, Molecular Biology, Biotechnology, Product Development, Immunology, FDA, Market Research, Research and Development (R&D), Mandarin, Chinese, Commertialization, Opportunity Assessment

Experience

Principal

OrbiMed

2025-2 - Present · 1 yr 8 mos

ArriVent, Belenos, Verdiva, Candid, RAPT, Sirius, QuantX, Pinnacle, Epigenic, MingHui Stealth-mode newco...

Director

OrbiMed

2023-2 - 2025-1 · 2 yrs

Vice President

OrbiMed

2022-2 - 2023-1 · 1 yr

Senior Associate

OrbiMed

2021-2 - 2022-1 · 1 yr

Senior Associate, Promoted to VP

Archived Page

2020-1 - 2020-12 · 1 yr

Sourced and led: Inventis Bio (SSE.688382), SentiBio (SNTI), Belief BioMed, PAQ Therapeutics, Nikang Therapeutics, D3Bio

Associate

Archived Page

2019-1 - 2019-12 · 1 yr

Senior Analyst

Archived Page

2018-1 - 2018-12 · 1 yr

Analyst

Archived Page

2017-7 - 2018-1 · 7 mos

Angel Investor

Life Science Angels

2017 - 2019 · 2 yrs

Associate Consultant

2014-9 - 2017-7 · 2 yrs 11 mos

San Francisco Bay Area

Genentech M&A strategy for orphan disease (led to the acquisition of SPARK Therapeutics); Gilead M&A strategy for oncology (led to the acquisition of Kite Pharma); Clinical trial, medical affairs, global launch strategies Global opportunity assessment for Novartis, Eli Lilly, Mirati; Phase 2-3 clinical trial design for pipeline pharmaceutical products

Certified Emergency Medical Technician

University of Pennsylvania

2011-5 - 2012-9 · 1 yr 5 mos

Greater Philadelphia Area

R&D

Allergan

2012 - 2012

Greater San Diego Area

Education

Stanford University School of Medicine

Biophysics, ML, Computer Vision

The Wharton School

Operations and Management

Magna cum laude

University of Pennsylvania

Roy Vagelos Dual Degree Program in Life Sciences & Management "LSM is an undergraduate dual-degree program administered jointly between Penn's College of Arts & Sciences and the Wharton School. Each year, the program enrolls approximately 25 exceptional students and offers them the opportunity to pursue an interdisciplinary curriculum combining bioscience and business, leading to the completion of two degrees: a Bachelor of Arts in a life science major, as well as a Bachelor of Science in Economics." Magna cum laude Certified Emergency Medical Technician, Medical Emergency Response Team Genomic and transcriptomic risk factors of AMD (Dwight E. Stambolian's lab)